# Anbio Biotechnology (NNNN) — Overview

NNNN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nnnn

## Price

Last close $3.30 on Oct 15, 2026. 52-week range $3.30 – $41.11.

## Company profile

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $8.6M |
| Revenue (quarter) | $8.6M |
| Revenue growth (year over year) | 5.64% |
| Gross profit (trailing twelve months) | $7.5M |
| Gross margin | 87.24% |
| Net income (trailing twelve months) | $6.4M |
| Net income (quarter) | $6.4M |
| Net income growth (year over year) | 169.86% |
| Net margin | 74.06% |
| Return on equity | 27.05% |
| EPS (trailing twelve months) | $0.15 |
| Book value per share | $0.21 |
| P/E (trailing twelve months) | 74.2 |
| Price to book | 15.7 |
| Debt to assets | 0.29% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Anbio Biotechnology (NNNN) profitable?

Yes. Anbio Biotechnology earned $6.4M in net income over the trailing twelve months, a net margin of 74.06%.

### How much revenue does Anbio Biotechnology (NNNN) make?

Anbio Biotechnology generated $8.6M in revenue over the trailing twelve months, up 5.64% year over year.

### What is NNNN's P/E ratio?

Anbio Biotechnology trades at 74.2 times trailing twelve-month earnings, on an EPS of $0.15.

### How do I buy stock in Anbio Biotechnology (NNNN)?

NNNN trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).